Turn medical, legal and regulatory review from a bottleneck into a business accelerator

In pharmaceutical marketing, speed only matters if content can move through review with confidence. The real challenge is not simply producing more assets. It is producing more compliant, localized and audience-specific assets across brands, channels and markets without overwhelming medical, legal and regulatory review teams.

For many organizations, medical-legal-regulatory review still sits too late in the process. Marketing creates at volume, local teams adapt for market needs, and reviewers are asked to catch issues after the work is already done. The result is familiar: preventable rework, long lead times, duplicated effort, strained handoffs between marketing, compliance and IT, and a slower path to market just when personalization matters most.

Publicis Sapient helps pharmaceutical and healthcare organizations change that operating model. With Bodhi and AskBodhi, we embed governance earlier in the workflow so teams can generate compliant-ready copy and imagery from the start, localize content for regional requirements more efficiently and give human reviewers the transparency and control they need. The outcome is a content supply chain that moves faster because compliance is built in—not bolted on.

The most effective way to reduce MLR friction is to stop sending avoidable issues downstream. That means moving compliance guardrails closer to content generation itself.

Publicis Sapient helps organizations embed brand, regulatory and technical guardrails into AI-assisted workflows from the beginning. Instead of treating governance as a final checkpoint, teams can generate compliant-ready outputs aligned to enterprise standards, regional requirements and channel needs. Automated pre-screening can flag potential issues before assets enter formal review, helping reduce the number of revision cycles and focusing attention on the areas that truly require expert judgment.

This is a practical workflow shift with immediate value. Reviewers spend less time correcting preventable errors such as missing elements, inconsistent versions or market-misaligned adaptations. Marketing teams gain a clearer path from brief to reviewable asset. And regional teams can localize faster without losing alignment to central guardrails.

In regulated industries, the goal is not to automate away judgment. It is to use AI where it adds the most value and preserve human oversight where it matters most.

Bodhi and AskBodhi support AI-assisted generation of personalized marketing materials including banners, emails and digital sales presentations, along with image recommendations, translation, localization and end-to-end campaign support. Within that workflow, AI can also support pre-screening and automated checks that identify regulatory red flags before content reaches formal review. That reduces manual burden, shortens cycle times and helps compliance teams engage at the right moments.

Human-in-the-loop review remains central, especially for high-stakes decisions, approvals and nuanced interpretation. The difference is that medical, legal and regulatory experts are no longer spending disproportionate time on issues that could have been prevented upstream. They can focus on substantiation, context, market nuance and risk-based decision-making—the work only people should do.

Speed without visibility creates risk. In pharma marketing, organizations need to know what was generated, how it was produced, what version was reviewed and where human oversight was applied.

That is why Publicis Sapient emphasizes observability, auditability and traceability as core capabilities, not afterthoughts. Bodhi-based workflows support version control, operational transparency and clearer accountability across the content lifecycle. This makes it easier for marketing, compliance and IT teams to work from a shared source of truth rather than chasing files, comments and approvals across disconnected systems.

With stronger traceability, organizations can support governance more effectively while also improving throughput. Teams gain better visibility into content status, review history and workflow progress. Compliance and platform stakeholders gain confidence that AI is operating within a controlled, observable environment. And business leaders gain a more scalable way to support growth without weakening oversight.

Localization is one of the biggest hidden drivers of MLR complexity. Each adaptation introduces new language, cultural and regulatory considerations, and manual localization often creates delays, duplication and inconsistency.

Publicis Sapient helps organizations integrate localization and translation into the same governed workflow used for content generation and review. Bodhi and AskBodhi can support regional replication, translation and market-specific adaptation so teams can move from approved global content to localized, market-ready variants faster and with more consistency.

This matters because regional relevance and regulatory discipline have to coexist. Local teams need flexibility to tailor messaging for healthcare professionals, patients and caregivers. Central teams need assurance that adapted assets still align to brand standards, privacy expectations and legal requirements. A connected workflow makes that balance operationally viable. Approved materials can be repurposed across banners, emails and other digital assets rather than recreated from the beginning for every market.

MLR bottlenecks are rarely caused by one team alone. They are usually symptoms of fragmented workflows and disconnected technology. Briefing happens in one place, copywriting in another, imagery in another, translation through separate vendors and review at the end. Every handoff adds time, cost and risk.

Publicis Sapient helps organizations move from that fragmented model to a governed content supply chain. Bodhi is designed to integrate with existing enterprise ecosystems and can be deployed in secure client environments or through SaaS-based API models, depending on organizational requirements. This flexibility is critical for regulated organizations where privacy, security, interoperability and control are non-negotiable.

By connecting creation, localization, review and deployment in a more continuous workflow, organizations reduce friction between marketing, compliance and IT teams. Marketing gains speed and reuse. Compliance gains guardrails, transparency and better-targeted review. IT gains a secure, observable architecture that supports production use rather than isolated experimentation.

Publicis Sapient has already applied this model with a leading global pharmaceutical company seeking to support hundreds of brands, diverse audiences and growing demand for personalized content across markets. Its legacy outsourcing approach created long lead times, high costs and limited ability to repurpose or localize content efficiently.

Using Bodhi and AskBodhi-powered workflows, Publicis Sapient helped transform content creation with tools for localization, translation, global replication, image recommendations and end-to-end campaign generation. Streamlined data ingestion, MLOps and creative workflows enabled teams to generate compliant-ready copy and imagery in seconds while maintaining guardrails through a secure architecture integrated with existing systems.

The results were significant: content production accelerated by up to 75%, with up to 45% cost reduction and faster time-to-market for global campaigns. Organizations also projected 35% to 50% cost reductions on select content creation tasks, with the ability to produce four to five times more content without increasing headcount. Just as importantly, teams were freed from repetitive manual work and able to focus on higher-value strategic priorities.

When MLR is treated as a late-stage checkpoint, it will always struggle to keep up with modern content demands. But when governance is embedded into the workflow—supported by guardrails, AI-assisted pre-screening, secure deployment, localization support and human-in-the-loop oversight—review becomes more targeted, more transparent and more scalable.

That is the shift Publicis Sapient helps regulated organizations make. Not compliance in the abstract, but a practical operating model that turns review from a drag on execution into a source of speed, trust and control.

For pharmaceutical marketers, legal teams, regulatory leaders and platform stakeholders, that means a better way to launch: compliant-ready content from the start, fewer preventable review cycles, stronger auditability, faster regional adaptation and more time for experts to focus on the decisions that matter most.

In a regulated industry, that is more than efficiency. It is a business advantage.

Relevant Links

• Pharmaceutical Company Scales Marketing with GenAI
• Pharmaceutical Company Scales Marketing with GenAI
• Pharmaceutical marketing leaders do not need another isolated AI feature. They need a better operating model.
• Deploy AI-powered pharma marketing operations on AWS with security, scale and control
• Global-to-Local Content Activation for Pharmaceutical Marketing
• IA generativa para el marketing farmacéutico en México: cómo escalar personalización, velocidad y cumplimiento sin multiplicar la complejidad (LATAM)
• FAQ (FAQ)
• FAQ (FAQ)
• What to Know About Publicis Sapient’s Generative AI Approach for Pharmaceutical Marketing: 10 Key Facts (LIST)
• What to Know About Publicis Sapient’s Generative AI Approach for Pharmaceutical Marketing: 10 Key Facts (LIST)
• L’IA générative au service du marketing pharmaceutique en Europe (Europe)